2014
DOI: 10.5414/np300658
|View full text |Cite
|
Sign up to set email alerts
|

Primary fourth ventricular B-cell lymphoma in an immunocompetent patient

Abstract: Letter to the Editor.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 11 publications
0
8
0
Order By: Relevance
“…[4,6] e presence 1]. [1,3,[7][8][9][10][11]13] e first report was dated 1977 by Werneck et al [13] Immunosuppression is a risk factor for the growth of this pathology and however is more prevalent in descriptions of cases in immunocompetent patients. e onset in adulthood is more prevalent, nevertheless, the mean age of presentation is 65 years [6,12] Clinical presentation is variable.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[4,6] e presence 1]. [1,3,[7][8][9][10][11]13] e first report was dated 1977 by Werneck et al [13] Immunosuppression is a risk factor for the growth of this pathology and however is more prevalent in descriptions of cases in immunocompetent patients. e onset in adulthood is more prevalent, nevertheless, the mean age of presentation is 65 years [6,12] Clinical presentation is variable.…”
Section: Discussionmentioning
confidence: 99%
“…[ 4 , 6 ] The presence of isolated fourth ventricle lesion is rare, with only eight cases previously reported [ Table 1 ]. [ 1 , 3 , 7 - 11 , 13 ] The first report was dated 1977 by Werneck et al . [ 13 ]…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, this advantage was lost when controlling for the total number of lesions [35]. Of patients with 4 th ventricular PCNSL, 35.3% of patients received ITC [811, 14, 16], and 52.9% of patients with 4 th ventricular PCNSL had gross subtotal or total resection [8, 1117, 22]. These patients also received various combinations of chemotherapy and chemoradiation so whether either of these treatment modalities conferred a survival benefit in this select patient population is not known.…”
Section: Discussionmentioning
confidence: 99%
“…PCNSLs within fourth ventricle are relatively seldom seen in immune-competent patients. To the best of our knowledge, only nine cases of PCNSL located at fourth ventricle have been reported in the literature (Table 1) [1][2][3][4][5][6][7][8][9].…”
Section: Discussionmentioning
confidence: 99%